Why the study?
Are higher baseline levels of total and high-molecular-weight adiponectin associated with a reduced risk of incident symptomatic peripheral artery disease in initially healthy women?
Are higher baseline levels of total and high-molecular-weight adiponectin associated with a reduced risk of incident symptomatic peripheral artery disease in initially healthy women?
Higher baseline levels of total and high-molecular-weight adiponectin are independently associated with a significantly lower risk of developing incident symptomatic peripheral artery disease in initially healthy women.
No takes yet. Share an insight, caveat, or question.
Supports inverse adiponectin-PAD link in women; hypothesis-generating and should not yet change risk stratification or practice.
Ho et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: